Protect Pharmaceutical Corporation
PRTT · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $60 | $81 | $33 | $69 |
| - Cash | $20 | $19 | $18 | $10 |
| + Debt | $4 | $4 | $4 | $4 |
| Enterprise Value | $44 | $66 | $19 | $63 |
| Revenue | $26 | $26 | $30 | $31 |
| % Growth | 2.6% | -13.7% | -3% | – |
| Gross Profit | $15 | $14 | $16 | $22 |
| % Margin | 55.7% | 56.1% | 53.9% | 71.5% |
| EBITDA | $9 | $9 | $10 | $22 |
| % Margin | 33.6% | 34.1% | 34.5% | 71.3% |
| Net Income | $7 | $7 | $10 | $26 |
| % Margin | 25.2% | 25.6% | 33.8% | 85.1% |
| EPS Diluted | 0.12 | 0.11 | 0.18 | 0.45 |
| % Growth | 9.1% | -38.9% | -60% | – |
| Operating Cash Flow | -$2 | $2 | $6 | -$0 |
| Capital Expenditures | -$2 | -$1 | -$1 | $0 |
| Free Cash Flow | -$5 | $2 | $6 | -$0 |